P&R Holding, one of the leading Italian groups in the chemical sector, was established in 2006.
The Group is mainly involved in the R&D, manufacturing, marketing and sales of finished dosage forms and APIs for the pharmaceutical industry. The Group's main objective is to provide clients and customers worldwide with high-quality products, ensuring the highest standards in production, environmental concerns and commercial reliability.

Innovation, competitiveness, internationalization, and quality are P&R Holding's leading principles and a prerequisite for the success of its customers and partners, whereas efficient integration capabilities of the Group's companies help manage business processes and create a stronger portfolio.

P&R Holding's daily business is determined by the following core values and principles:

  • High Quality
  • Innovative Technological Expertise
  • Competitiveness in R&D
  • Customer Satisfaction
  • Focus on Human Resources
  • Responsible Partnership

For additional information on P&R Holding, visit

Fidia Farmaceutici S.p.A. is a FDF company which operates in numerous therapeutic areas, providing specific, innovative treatments for commonly occurring pathologies with major socio-economic impact, namely:

  • joint healthcare
  • advanced wound care
  • dermatology
  • neurology
  • dermo-aesthetics

Fidia's pipeline of products comprises medicinal products, medical devices and nutritional supplements.
Today, Fidia is expanding its global reach and successfully distributes its products worldwide, through an established network of international partners operating in the pharmaceutical and biomedical sectors, both on a global and local scale.

The Group has other members besides Fidia Farmaceutici S.p.A., all reinforcing its marketing potential:

  • Olon S.p.A.
  • Fidia Pharma USA Inc
  • Fidia Pharma GmbH
  • Fidia Pharma Kazakhstan

For additional information on FIDIA FARMACEUTICI S.p.A. Group, visit